Lennart Minthon (Former)
41 – 50 of 304
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease
- Contribution to journal › Article
-
Mark
Copeptin, a Marker of Vasopressin, Predicts Vascular Dementia but not Alzheimer's Disease
- Contribution to journal › Article
-
Mark
Reference measurement procedure for CSF amyloid beta (Aβ)1–42 and the CSF Aβ1–42/Aβ1–40 ratio – a cross-validation study against amyloid PET
- Contribution to journal › Article
-
Mark
Reliability, validity and clinical correlates of the Quality of Life in Alzheimer's disease (QoL-AD) scale in medical inpatients
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid soluble TREM2 in aging and Alzheimer's disease
- Contribution to journal › Article
-
Mark
White matter lesions highly influence group comparison of diffusion tensor imaging metrics
(2016) ISMRM, 2016
- Contribution to conference › Poster
- 2015
-
Mark
CSF biomarkers for the differential diagnosis of Alzheimer's disease. A large-scale international multicenter study.
- Contribution to journal › Article
-
Mark
An Integrated Workflow for Multiplex CSF Proteomics and Peptidomics-Identification of Candidate Cerebrospinal Fluid Biomarkers of Alzheimer's Disease
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease.
- Contribution to journal › Article
-
Mark
Low IL-8 is associated with anxiety in suicidal patients: genetic variation and decreased protein levels.
- Contribution to journal › Article
